With a history dating back to 1977, OSYPKA AG has been a pioneer in various medical fields, setting industry standards with their breakthrough products such as fracture-resistant implantable electrodes and the world's first high-frequency ablation generator for treating heart rhythm disorders. Today, OSYPKA offers a wide range of branded products in the areas of cardiac stimulation, cardiac surgery, electrophysiology, and interventional and pediatric cardiology. In addition to their headquarters in Germany, the company has additional locations in the United States and the Czech Republic. OSYPKA AG also serves as a trusted partner for international medical technology companies, providing contract manufacturing and development services. As a majority-owned subsidiary of the charitable Peter Osypka Foundation, the family-owned company is committed to promoting medical research and charitable projects in developing countries.